These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22536258)

  • 1. Biologicals.
    de Carvalho JF; Appenzeller S; Shoenfeld Y
    Int J Rheumatol; 2012; 2012():892873. PubMed ID: 22536258
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologicals in rheumatoid arthritis: current and future.
    Avci AB; Feist E; Burmester GR
    RMD Open; 2015; 1(1):e000127. PubMed ID: 26535144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phototherapy in the era of biologicals].
    Lehmann P
    Hautarzt; 2013 May; 64(5):345-8. PubMed ID: 23595889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologicals in childhood severe asthma: the European PERMEABLE survey on the
    Santos-Valente E; Buntrock-Döpke H; Abou Taam R; Arasi S; Bakirtas A; Lozano Blasco J; Bønnelykke K; Craiu M; Cutrera R; Deschildre A; Elnazir B; Fleming L; Frey U; Gappa M; Nieto García A; Skamstrup Hansen K; Hanssens L; Jahnz-Rozyk K; Jesenak M; Kerzel S; Kopp MV; Koppelman GH; Krivec U; MacLeod KA; Mäkelä M; Melén E; Mezei G; Moeller A; Moreira A; Pohunek P; Minić P; Rutjes NWP; Sammut P; Schwerk N; Szépfalusi Z; Turkalj M; Tzotcheva I; Ulmeanu A; Verhulst S; Xepapadaki P; Niggel J; Vijverberg S; Maitland-van der Zee AH; Potočnik U; Reinartz SM; van Drunen CM; Kabesch M
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34409097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps.
    van der Rijst LP; van Royen-Kerkhof A; Pasmans SGMA; Schappin R; de Bruin-Weller MS; de Graaf M
    J Dermatolog Treat; 2023 Dec; 34(1):2254567. PubMed ID: 37664977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Like a fish on dry land': an explorative qualitative study into severe asthma and the impact of biologicals on patients' everyday life.
    de Graaff MB; Bendien SA; van de Bovenkamp HM
    J Asthma; 2022 May; 59(5):980-988. PubMed ID: 33625306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions.
    Png WY; Kwan YH; Lim KK; Chew EH; Lui NL; Tan CS; Østbye T; Thumboo J; Fong W
    Eur J Hosp Pharm; 2019 May; 26(3):163-169. PubMed ID: 31428325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologicals in atopic disease in pregnancy: An EAACI position paper.
    Pfaller B; José Yepes-Nuñez J; Agache I; Akdis CA; Alsalamah M; Bavbek S; Bossios A; Boyman O; Chaker A; Chan S; Chatzipetrou A; du Toit G; Jutel M; Kauppi P; Kolios A; Li C; Matucci A; Marson A; Bendien S; Palomares O; Rogala B; Szepfalusi Z; Untersmayr E; Vultaggio A; Eiwegger T
    Allergy; 2021 Jan; 76(1):71-89. PubMed ID: 32189356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smallholder farmers' knowledge, attitudes, and practices (KAP) regarding agricultural inputs with a focus on agricultural biologicals.
    Mulugeta T; Ilomo M; Mueke A; Onyango C; Matsaunyane L; Kritzinger Q; Alexandersson E
    Heliyon; 2024 Feb; 10(4):e26719. PubMed ID: 38434028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-Patent Biologicals and Biosimilars Tendering in Europe-A Proposal towards More Sustainable Practices.
    Barbier L; Simoens S; Soontjens C; Claus B; Vulto AG; Huys I
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34073861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).
    Pfaar O; Klimek L; Hamelmann E; Kleine-Tebbe J; Taube C; Wagenmann M; Werfel T; Brehler R; Novak N; Mülleneisen N; Becker S; Worm M
    Allergol Select; 2021; 5():140-147. PubMed ID: 33842829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
    Agache I; Beltran J; Akdis C; Akdis M; Canelo-Aybar C; Canonica GW; Casale T; Chivato T; Corren J; Del Giacco S; Eiwegger T; Firinu D; Gern JE; Hamelmann E; Hanania N; Mäkelä M; Hernández-Martín I; Nair P; O'Mahony L; Papadopoulos NG; Papi A; Park HS; Pérez de Llano L; Posso M; Rocha C; Quirce S; Sastre J; Shamji M; Song Y; Steiner C; Schwarze J; Alonso-Coello P; Palomares O; Jutel M
    Allergy; 2020 May; 75(5):1023-1042. PubMed ID: 32034960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of procurement, distribution, availability, and utilization of rabies biologicals for postexposure prophylaxis in seven states of India.
    D Hanumanthaiah AN; Haradanhalli RS
    Indian J Public Health; 2019 Sep; 63(Supplement):S31-S36. PubMed ID: 31603089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to biologicals in Crohn's disease in ten European countries.
    Péntek M; Lakatos PL; Oorsprong T; Gulácsi L; Pavlova M; Groot W; Rencz F; Brodszky V; Baji P; Crohn's Disease Research Group
    World J Gastroenterol; 2017 Sep; 23(34):6294-6305. PubMed ID: 28974896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource use and cost of care with biologicals in Crohn's disease in South Africa: a retrospective analysis from a payer perspective.
    Miot J; Smith S; Bhimsan N
    Int J Clin Pharm; 2016 Aug; 38(4):880-7. PubMed ID: 27118462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I; Stacey G; Petricciani J; Sheets R;
    Biologicals; 2010 Jan; 38(1):162-9. PubMed ID: 19818645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety-related regulatory actions for biologicals approved in the United States and the European Union.
    Giezen TJ; Mantel-Teeuwisse AK; Straus SM; Schellekens H; Leufkens HG; Egberts AC
    JAMA; 2008 Oct; 300(16):1887-96. PubMed ID: 18940975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice.
    Vermeer NS; Giezen TJ; Zastavnik S; Wolff-Holz E; Hidalgo-Simon A
    Clin Pharmacol Ther; 2019 Apr; 105(4):962-969. PubMed ID: 30460997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy.
    Ling J; Koren G
    Expert Rev Vaccines; 2016; 15(2):239-56. PubMed ID: 26642867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.